-
公开(公告)号：US20200247801A1
公开(公告)日：2020-08-06
申请号：US16753630
申请日：2018-10-04
IPC分类号： C07D471/04 , C07D413/10 , C07D407/12 , C07D413/14
摘要： The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.
-
公开(公告)号：US20160060273A1
公开(公告)日：2016-03-03
申请号：US14775265
申请日：2014-03-13
发明人： Shizuo KASAI , Masaki OGINO , Ryo MIZOJIRI , Takeshi YAMASAKI , Hideki HIROSE , Nobuyuki TAKAKURA , Tohru YAMASHITA , Sachie MORIMOTO , Takashi NAKAHATA , Asato KINA
IPC分类号： C07D498/10
CPC分类号： C07D498/10
摘要： Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
摘要翻译： 提供具有下式（1）表示的化合物或其盐，其具有SSTR5拮抗作用：其中每个符号具有与说明书中相同的定义。
-
公开(公告)号：US20230278999A1
公开(公告)日：2023-09-07
申请号：US17819818
申请日：2022-08-15
IPC分类号： C07D471/04 , C07D407/12 , C07D413/10 , C07D413/14
CPC分类号： C07D471/04 , C07D407/12 , C07D413/10 , C07D413/14
摘要： The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer’s disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.
The present invention relates to a compound represented by the formula (I):
wherein each symbol is as described in the specification, or a salt thereof.-
公开(公告)号：US20200270243A1
公开(公告)日：2020-08-27
申请号：US16753613
申请日：2018-10-04
发明人： Shinji NAKAMURA , Satoshi MIKAMI , Tomoaki HASUI , Tohru YAMASHITA , Shinji MORIMOTO , Hidekazu TOKUHARA , Norio OYABU , Masami YAMADA , Atsuko OCHIDA , Kazuaki TAKAMI , Xin LIU
IPC分类号： C07D471/04 , C07D519/00 , C07D487/04 , A61K9/20
摘要： The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.
-
-
-
搜索结果
4 条记录 (耗时 0.026 秒)
